205 related articles for article (PubMed ID: 20943809)
1. Clinically relevant progestins regulate neurogenic and neuroprotective responses in vitro and in vivo.
Liu L; Zhao L; She H; Chen S; Wang JM; Wong C; McClure K; Sitruk-Ware R; Brinton RD
Endocrinology; 2010 Dec; 151(12):5782-94. PubMed ID: 20943809
[TBL] [Abstract][Full Text] [Related]
2. The effect of progesterone and synthetic progestins on serum- and estradiol-stimulated proliferation of human breast cancer cells.
Seeger H; Wallwiener D; Mueck AO
Horm Metab Res; 2003 Feb; 35(2):76-80. PubMed ID: 12734785
[TBL] [Abstract][Full Text] [Related]
3. Progestins and breast cancer hallmarks: The role of the ERK1/2 and JNK pathways in estrogen receptor positive breast cancer cells.
Louw-du Toit R; Simons M; Africander D
J Steroid Biochem Mol Biol; 2024 Mar; 237():106440. PubMed ID: 38048919
[TBL] [Abstract][Full Text] [Related]
4. Nestorone: a progestin with a unique pharmacological profile.
Kumar N; Koide SS; Tsong Y; Sundaram K
Steroids; 2000; 65(10-11):629-36. PubMed ID: 11108869
[TBL] [Abstract][Full Text] [Related]
5. Divergent impact of progesterone and medroxyprogesterone acetate (Provera) on nuclear mitogen-activated protein kinase signaling.
Nilsen J; Brinton RD
Proc Natl Acad Sci U S A; 2003 Sep; 100(18):10506-11. PubMed ID: 12925744
[TBL] [Abstract][Full Text] [Related]
6. Estradiol 17beta inhibition of LDL oxidation and endothelial cell cytotoxicity is opposed by progestins to different degrees.
Zhu X; Bonet B; Knopp RH
Atherosclerosis; 2000 Jan; 148(1):31-41. PubMed ID: 10580168
[TBL] [Abstract][Full Text] [Related]
7. Differential off-target glucocorticoid activity of progestins used in endocrine therapy.
Komane M; Avenant C; Louw-du Toit R; Africander DJ; Hapgood JP
Steroids; 2022 Jun; 182():108998. PubMed ID: 35271867
[TBL] [Abstract][Full Text] [Related]
8. Effects of estradiol and progestogens on human breast cells: regulation of sex steroid receptors.
Chen FP; Chien MH; Chen HY; Huang TS; Ng YT
Taiwan J Obstet Gynecol; 2013 Sep; 52(3):365-73. PubMed ID: 24075375
[TBL] [Abstract][Full Text] [Related]
9. Progestin-mediated activation of MAPK and AKT in nuclear progesterone receptor negative breast epithelial cells: The role of membrane progesterone receptors.
Salazar M; Lerma-Ortiz A; Hooks GM; Ashley AK; Ashley RL
Gene; 2016 Oct; 591(1):6-13. PubMed ID: 27349565
[TBL] [Abstract][Full Text] [Related]
10. Contraceptive progestins. Various 11-substituents combined with four 17-substituents: 17alpha-ethynyl, five- and six-membered spiromethylene ethers or six-membered spiromethylene lactones.
Schoonen WG; Deckers G; de Gooijer ME; de Ries R; Mathijssen-Mommers G; Hamersma H; Kloosterboer HJ
J Steroid Biochem Mol Biol; 2000 Oct; 74(3):109-23. PubMed ID: 11086230
[TBL] [Abstract][Full Text] [Related]
11. Differential metabolism of clinically-relevant progestogens in cell lines and tissue: Implications for biological mechanisms.
Skosana SB; Woodland JG; Cartwright M; Enfield K; Komane M; Louw-du Toit R; van der Spuy Z; Avenant C; Africander D; Storbeck KH; Hapgood JP
J Steroid Biochem Mol Biol; 2019 May; 189():145-153. PubMed ID: 30822501
[TBL] [Abstract][Full Text] [Related]
12. Effects of progestins of human proliferative endometrium: an in vitro model of potential clinical relevance.
Illouz S; Dales JP; Sferlazzo K; Garcia S; Carpentier-Meunier S; Boubli L; Lavaut MN; Charpin C
Int J Mol Med; 2003 Oct; 12(4):517-23. PubMed ID: 12964029
[TBL] [Abstract][Full Text] [Related]
13. Preclinical evaluation of norgestimate, a progestin with minimal androgenic activity.
Phillips A; Hahn DW; McGuire JL
Am J Obstet Gynecol; 1992 Oct; 167(4 Pt 2):1191-6. PubMed ID: 1415445
[TBL] [Abstract][Full Text] [Related]
14. In vitro characterization of trimegestone: a new potent and selective progestin.
Zhang Z; Lundeen SG; Zhu Y; Carver JM; Winneker RC
Steroids; 2000; 65(10-11):637-43. PubMed ID: 11108870
[TBL] [Abstract][Full Text] [Related]
15. Certain progestins prevent the enhancing effect of 17beta-estradiol on NO-mediated inhibition of platelet aggregation by endothelial cells.
Zerr-Fouineau M; Jourdain M; Boesch C; Hecker M; Bronner C; Schini-Kerth VB
Arterioscler Thromb Vasc Biol; 2009 Apr; 29(4):586-93. PubMed ID: 19096000
[TBL] [Abstract][Full Text] [Related]
16. Functional role of progestin and the progesterone receptor in the suppression of spermatogenesis in rodents.
Lue Y; Wang C; Lydon JP; Leung A; Li J; Swerdloff RS
Andrology; 2013 Mar; 1(2):308-17. PubMed ID: 23408752
[TBL] [Abstract][Full Text] [Related]
17. The association between progestins, nuclear receptors expression and inflammation in endometrial stromal cells from women with endometriosis.
Grandi G; Mueller MD; Bersinger NA; Facchinetti F; McKinnon BD
Gynecol Endocrinol; 2017 Sep; 33(9):712-715. PubMed ID: 28412861
[TBL] [Abstract][Full Text] [Related]
18. Relative progestational and androgenic activity of four progestins used for male hormonal contraception assessed in vitro in relation to their ability to suppress LH secretion in the castrate male rat.
Attardi BJ; Koduri S; Hild SA
Mol Cell Endocrinol; 2010 Oct; 328(1-2):16-21. PubMed ID: 20599585
[TBL] [Abstract][Full Text] [Related]
19. Impact of progestins on estrogen-induced neuroprotection: synergy by progesterone and 19-norprogesterone and antagonism by medroxyprogesterone acetate.
Nilsen J; Brinton RD
Endocrinology; 2002 Jan; 143(1):205-12. PubMed ID: 11751611
[TBL] [Abstract][Full Text] [Related]
20. Medroxyprogesterone acetate antagonizes estrogen up-regulation of brain mitochondrial function.
Irwin RW; Yao J; Ahmed SS; Hamilton RT; Cadenas E; Brinton RD
Endocrinology; 2011 Feb; 152(2):556-67. PubMed ID: 21159850
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
